OTC drug interactions "not a significant public health problem" -- Degge report.
This article was originally published in The Tan Sheet
Executive Summary
OTC DRUG INTERACTIONS "NOT SIGNIFICANT PUBLIC HEALTH PROBLEM," DEGGE REPORT concludes. Contracted by the Non-prescription Drug Manufacturers Association, the Nov. 1 report by the Degge Group, Ltd. reviews epidemiological data on OTC drug interactions against the backdrop of OTC use patterns in the U.S. The report was included in NDMA's Nov. 14 proposal to FDA on OTC label reform.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning